Stage 2non-small cell lung cancer(NSCLC) is localized cancer that has not spread beyond one lung or the locallymph nodeson the same side of the chest. Any lung cancer diagnosis is serious, but being in thisearly stagemeans your disease is very treatable, and your chances for a long-term...
Treatment of stage II non-small cell lung cancer. Chest 2003;123(Suppl 1):188-201S.Scott WJ, Howington J, Movsas B. Treatment of stage II non-small cell lung cancer. Chest 2003; 123: 188S - 201SScott WJ, Howington J and Movsas B (2003) Treatment of stage II non-small cell ...
Results The best clinical evidence for Ⅰ and Ⅱ stage non-small cell lung cancer patients showed that in the patients with resectable nonsmall cell lung cancer, postoperative adjuvant radiotherapy and chemotherapy could not improve survival compared with surgery alone. We did not find evidence which...
(ctDNA) is commonly used for molecular profiling in patients with advanced-stage non-small-cell lung cancer (NSCLC). The authors of this Review summarize the available evidence on the potential utility of incorporating ctDNA in the management of those with early stage and locally advanced NSCLC ...
Supervisor:Ministry of Education of the People's Republic of ChinaSponsor:Sichuan University Editor-in-chief:LI Youping Publishing period: MonthlyISSN:1672-2531CN:51–1656/R WeChat Chinese Journal of Evidence-Based Medicine| 2009, 09(12): 1336-1338 ...
Surgeons prefer pneumonectomy over lobectomy for non-small cell lung cancer (NSCLC) with hilar (T1N1M0 or T2N1M0) disease. We investigated whether survival of stage-II (N1) NSCLC patients (pts) after lobectomy is inferior to that after pneumonectomy and whether tumor histology affects survival....
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.What are the subtypes of NSCLC?Squamous cell carcinoma is found in cells that line the airways of the lungs. It is usually found in the middle of the lung. Adenocarcinoma is found in cells that produce mucus. It...
In an ongoing, open-label, single-arm phase II study ( NCT02927301 ), 181 patients with untreated, resectable, stage IB–IIIB non-small cell lung cancer received two doses of neoadjuvant atezolizumab monotherapy. The primary end point was major pathologi
The optimal treatment of stage ⅢA-N2 non-small cell lung cancer(NSCLC)remains controversial.Results of primary surgery alone are not satisfied.Surgery after induction chemotherapy yields better outcomes compared to resection only which has been widely accepted.Randomized studies show induction chemotherapy...
Survival in early-stage non-small cell lung cancer.HumansCarcinoma, Non-Small-Cell LungLung NeoplasmsSurvival RateTumor Markers, BiologicalNeoplasm StagingPrognosisThe duration of survival in early-stage lung cancer (stages I and II) varies between reports in the literature. Several reasons account ...